Summary: In today’s Carbohydrates Can Kill Podcast Show, I am presenting to you the second episode of a specially series on Carbohydrates and Cancer. I am greatly honored to have Professor Thomas Seyfried as my featured guest. To effectively preventing and treating diseases, we must first know their etiology that helps create the best clinical strategies. Unfortunately, exploring the etiology of diseases is difficult in most of the cases. The hope of a breakthrough with a correct study result or results is even slimmer, if the direction of a study is wrong, based on a wrong hypothesis. In addition, the study conclusion could be skewed because of mishandlings in the study method and interpretation. Therefore, sound hypotheses are an important and only come from those researchers and clinicians who are brave to break themselves away from the mainstream and work hard for finding the truth. Professor Seyfried and his coworkers have devoted to cancer research particularly in the association between diet and cancer. I am sure that, like myself, you want to hear what Professor Seyfried is going to share with us his knowledge in this important topic. About Professor Thomas Seyfried: Professor Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. Dr. Seyfried served as a Chemist and Bacteriologist in the Massachusetts Department of Public Health. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine, and he went on to serve as an Assistant Professor in Neurology in the same department while at Yale. Prior to receiving full professorship, Dr. Seyfried was an Associate Professor in the Department of Biology at Boston College. Dr. Seyfried also served with distinction in the United States Army during the Vietnam War, receiving numerous medals and commendations. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, the American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society. Dr. Seyfried has participated on the editorial board of the Journal of Neurochemistry, and is presently on the editorial boards of Nutrition and Metabolism, Neurochemical Research, the Journal of Lipid Research and ASN Neuro. Dr. Seyfried’s research program focuses on gene environmental interactions related to complex diseases, such as epilepsy, autism, brain cancer, and neurodegenerative (the GM1 and GM2 gangliosidoses) diseases. He also recently served as chair, Scientific Advisory Committee, National Tay-Sachs & Allied Disease Association. His laboratory explores neurological disease management using lipid biochemistry and principles of metabolic control theory. This theory is based on the idea that compensatory brain metabolic pathways are capable of modifying the pathogenesis of complex diseases despite the continued presence of the genetic or environmental defects responsible for the disease. By shifting the brain metabolic environment, diet and drug therapies can potentially mask or neutralize molecular pathology. The diet therapies used include caloric restriction, fasting, and the low carbohydrate, high fat, ketogenic diet. These diseases include epilepsy, autism, cancer, and lipid storage disease. The goal is to manage complex diseases with non-toxic therapies that have immediate translational benefit to the clinic. Order my book: CarbohydratesCanKill. Want to support my campaign? Please click the “Donate” button in the right-hand column of this page. ContactMe
